Keywords: European Union, EFPIA, Research, Drug development
EU Commission and pharma industry launch second call for research proposal towards more efficient drug development methods
Article | 30 November 2009
Europe’s Innovative Medicines Initiative (IMI) officially launched its second Call for proposals. The public-private partnership between the European Commission ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
